Cost–utility analysis of a multicomponent intervention for fibromyalgia syndrome in primary care versus usual clinical practice: study protocol for an economic evaluation of a randomised control trial
Introduction Fibromyalgia syndrome (FMS) imposes a high cost on society. The significant economic burden from the use of healthcare and, especially, social resources is a spur to revising the usual clinical care (UCC) and to improving treatment strategies. FMS has a deleterious effect on the quality...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-02-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/11/2/e043562.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846165765088083968 |
|---|---|
| author | Anna Berenguera Victoria Mailen Arfuch Rosa Caballol Angelats Carina Aguilar Martín Noèlia Carrasco-Querol Maria Cinta Sancho Sol Gemma González Serra Immaculada Fusté Anguera Alessandra Queiroga Gonçalves José Fernández Sáez Marc Casajuana |
| author_facet | Anna Berenguera Victoria Mailen Arfuch Rosa Caballol Angelats Carina Aguilar Martín Noèlia Carrasco-Querol Maria Cinta Sancho Sol Gemma González Serra Immaculada Fusté Anguera Alessandra Queiroga Gonçalves José Fernández Sáez Marc Casajuana |
| author_sort | Anna Berenguera |
| collection | DOAJ |
| description | Introduction Fibromyalgia syndrome (FMS) imposes a high cost on society. The significant economic burden from the use of healthcare and, especially, social resources is a spur to revising the usual clinical care (UCC) and to improving treatment strategies. FMS has a deleterious effect on the quality of life (QOL) and productivity, which considerably increase the indirect costs to society. This study reports an economic evaluation comparing the cost and health benefits in a multicomponent intervention programme and UCC of patients with FMS who attend primary healthcare centres of the Gerència Territorial Terres de L’Ebre region of Catalonia, Spain. This article is linked to the pre-results of a randomised control trial study on the implementation of this intervention programme (ClinicalTrials.gov: NCT04049006).Method and analysis A cost–utility analysis will be conducted from a societal perspective. Quality-adjusted life years will be calculated from the results of the SF-36 questionnaire, a QOL measurement instrument. Direct and indirect healthcare costs will be obtained from official prices and reports published by the Spanish Public Health Administration and the National Statistics Institute. The incremental cost–utility ratio will be estimated to compare the two healthcare practices. Deterministic sensitivity analysis will also be used to compare different cost scenarios, modifying the items with the highest weight in the cost composition.Ethics and dissemination The Clinical Research Ethics Committee of the IDIAPJGol Institute approved this study on 25 April 2018 (code P18/068) in accordance with the Helsinki/Tokyo Declaration. Information will be provided orally and in writing to participants, and their informed consent will be required. Participant anonymity will be guaranteed. The dissemination strategy includes publications in scientific journals and presentations in local and national media and at academic conferences.Trial registration number: NCT04049006; Pre-results. |
| format | Article |
| id | doaj-art-7dca73f0b2d34d6b84f16468eafb3b98 |
| institution | Kabale University |
| issn | 2044-6055 |
| language | English |
| publishDate | 2021-02-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj-art-7dca73f0b2d34d6b84f16468eafb3b982024-11-17T05:30:12ZengBMJ Publishing GroupBMJ Open2044-60552021-02-0111210.1136/bmjopen-2020-043562Cost–utility analysis of a multicomponent intervention for fibromyalgia syndrome in primary care versus usual clinical practice: study protocol for an economic evaluation of a randomised control trialAnna Berenguera0Victoria Mailen Arfuch1Rosa Caballol Angelats2Carina Aguilar Martín3Noèlia Carrasco-Querol4Maria Cinta Sancho Sol5Gemma González Serra6Immaculada Fusté Anguera7Alessandra Queiroga Gonçalves8José Fernández Sáez9Marc Casajuana10Central Research Unit, IDIAP Jordi Gol, Barcelona, Catalunya, SpainUnitat de Suport a la Recerca Terres de l’Ebre, IDIAP Jordi Gol, Barcelona, Catalunya, SpainEquip d’Atenció Primària Tortosa Est, Institut Català de la Salut, Tortosa, Catalonia, Spain3 Unitat de Suport a la Recerca Terres de l’Ebre, Fundació Institut Universitari per a la Recerca al’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Tortosa, SpainUnitat de Suport a la Recerca Terres de l’Ebre, IDIAP Jordi Gol, Barcelona, Catalunya, SpainUnitat d’Expertesa en Sindromes de Sensibilització Central Terres de l’Ebre, Institut Català de la Salut, Tortosa, Catalonia, SpainUnitat de Suport a la Recerca Terres de l’Ebre, IDIAP Jordi Gol, Barcelona, Catalunya, SpainEquip d’Atenció Primària Tortosa Est, Institut Català de la Salut, Tortosa, Catalonia, Spain3 Unitat de Suport a la Recerca Terres de l’Ebre, Fundació Institut Universitari per a la Recerca al’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Tortosa, SpainUnitat de Suport a la Recerca Terres de l’Ebre, IDIAP Jordi Gol, Barcelona, Catalunya, SpainCentral Research Unit, IDIAP Jordi Gol, Barcelona, Catalunya, SpainIntroduction Fibromyalgia syndrome (FMS) imposes a high cost on society. The significant economic burden from the use of healthcare and, especially, social resources is a spur to revising the usual clinical care (UCC) and to improving treatment strategies. FMS has a deleterious effect on the quality of life (QOL) and productivity, which considerably increase the indirect costs to society. This study reports an economic evaluation comparing the cost and health benefits in a multicomponent intervention programme and UCC of patients with FMS who attend primary healthcare centres of the Gerència Territorial Terres de L’Ebre region of Catalonia, Spain. This article is linked to the pre-results of a randomised control trial study on the implementation of this intervention programme (ClinicalTrials.gov: NCT04049006).Method and analysis A cost–utility analysis will be conducted from a societal perspective. Quality-adjusted life years will be calculated from the results of the SF-36 questionnaire, a QOL measurement instrument. Direct and indirect healthcare costs will be obtained from official prices and reports published by the Spanish Public Health Administration and the National Statistics Institute. The incremental cost–utility ratio will be estimated to compare the two healthcare practices. Deterministic sensitivity analysis will also be used to compare different cost scenarios, modifying the items with the highest weight in the cost composition.Ethics and dissemination The Clinical Research Ethics Committee of the IDIAPJGol Institute approved this study on 25 April 2018 (code P18/068) in accordance with the Helsinki/Tokyo Declaration. Information will be provided orally and in writing to participants, and their informed consent will be required. Participant anonymity will be guaranteed. The dissemination strategy includes publications in scientific journals and presentations in local and national media and at academic conferences.Trial registration number: NCT04049006; Pre-results.https://bmjopen.bmj.com/content/11/2/e043562.full |
| spellingShingle | Anna Berenguera Victoria Mailen Arfuch Rosa Caballol Angelats Carina Aguilar Martín Noèlia Carrasco-Querol Maria Cinta Sancho Sol Gemma González Serra Immaculada Fusté Anguera Alessandra Queiroga Gonçalves José Fernández Sáez Marc Casajuana Cost–utility analysis of a multicomponent intervention for fibromyalgia syndrome in primary care versus usual clinical practice: study protocol for an economic evaluation of a randomised control trial BMJ Open |
| title | Cost–utility analysis of a multicomponent intervention for fibromyalgia syndrome in primary care versus usual clinical practice: study protocol for an economic evaluation of a randomised control trial |
| title_full | Cost–utility analysis of a multicomponent intervention for fibromyalgia syndrome in primary care versus usual clinical practice: study protocol for an economic evaluation of a randomised control trial |
| title_fullStr | Cost–utility analysis of a multicomponent intervention for fibromyalgia syndrome in primary care versus usual clinical practice: study protocol for an economic evaluation of a randomised control trial |
| title_full_unstemmed | Cost–utility analysis of a multicomponent intervention for fibromyalgia syndrome in primary care versus usual clinical practice: study protocol for an economic evaluation of a randomised control trial |
| title_short | Cost–utility analysis of a multicomponent intervention for fibromyalgia syndrome in primary care versus usual clinical practice: study protocol for an economic evaluation of a randomised control trial |
| title_sort | cost utility analysis of a multicomponent intervention for fibromyalgia syndrome in primary care versus usual clinical practice study protocol for an economic evaluation of a randomised control trial |
| url | https://bmjopen.bmj.com/content/11/2/e043562.full |
| work_keys_str_mv | AT annaberenguera costutilityanalysisofamulticomponentinterventionforfibromyalgiasyndromeinprimarycareversususualclinicalpracticestudyprotocolforaneconomicevaluationofarandomisedcontroltrial AT victoriamailenarfuch costutilityanalysisofamulticomponentinterventionforfibromyalgiasyndromeinprimarycareversususualclinicalpracticestudyprotocolforaneconomicevaluationofarandomisedcontroltrial AT rosacaballolangelats costutilityanalysisofamulticomponentinterventionforfibromyalgiasyndromeinprimarycareversususualclinicalpracticestudyprotocolforaneconomicevaluationofarandomisedcontroltrial AT carinaaguilarmartin costutilityanalysisofamulticomponentinterventionforfibromyalgiasyndromeinprimarycareversususualclinicalpracticestudyprotocolforaneconomicevaluationofarandomisedcontroltrial AT noeliacarrascoquerol costutilityanalysisofamulticomponentinterventionforfibromyalgiasyndromeinprimarycareversususualclinicalpracticestudyprotocolforaneconomicevaluationofarandomisedcontroltrial AT mariacintasanchosol costutilityanalysisofamulticomponentinterventionforfibromyalgiasyndromeinprimarycareversususualclinicalpracticestudyprotocolforaneconomicevaluationofarandomisedcontroltrial AT gemmagonzalezserra costutilityanalysisofamulticomponentinterventionforfibromyalgiasyndromeinprimarycareversususualclinicalpracticestudyprotocolforaneconomicevaluationofarandomisedcontroltrial AT immaculadafusteanguera costutilityanalysisofamulticomponentinterventionforfibromyalgiasyndromeinprimarycareversususualclinicalpracticestudyprotocolforaneconomicevaluationofarandomisedcontroltrial AT alessandraqueirogagoncalves costutilityanalysisofamulticomponentinterventionforfibromyalgiasyndromeinprimarycareversususualclinicalpracticestudyprotocolforaneconomicevaluationofarandomisedcontroltrial AT josefernandezsaez costutilityanalysisofamulticomponentinterventionforfibromyalgiasyndromeinprimarycareversususualclinicalpracticestudyprotocolforaneconomicevaluationofarandomisedcontroltrial AT marccasajuana costutilityanalysisofamulticomponentinterventionforfibromyalgiasyndromeinprimarycareversususualclinicalpracticestudyprotocolforaneconomicevaluationofarandomisedcontroltrial |